Skip to main content

Market Overview

Penny Stock Ticks Higher On Deal To Develop Immune-Supportive Formula


Shares of actively-traded penny stock Guardion Health Sciences Inc (NASDAQ: GHSI) are advancing after the company announced an agreement for developing an immuno-supportive formula.

San Diego, California-based Guardion said a publicly-listed Malaysian company, going by the name Ho Wah Genting Berhad, has contracted Guardion and its recently-acquired subsidiary NutriGuard, to develop a proprietary formula to meet the demands of the Malaysian company's customers for an immune-supportive product.

See Also: 18 Medical Stocks To Watch Amid The Coronavirus Outbreak

Mark McCarty, founder of NutriGuard and a leader in scientific validation of nutrition-based therapies for potentiating the type 1 interferon response to RNA viruses, would be tasked with developing this formula, Guardion said. The company clarified that the formula would provide immuno-supportive and anti-inflammatory benefits to its users but hasn't been tested yet or is intended to specifically address the symptoms of the current COVID-19 virus.

Guardion shares were rising 4.5% to 31 cents.


Related Articles (GHSI)

View Comments and Join the Discussion!

Posted-In: Coronavirus Covid-19News Penny Stocks Health Care Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at